Multivariate analyses for prognostic factors affecting the OS of patients with DLBCL including MYC expression and genetic aberration of MYC showed that CD24 expression is a candidate prognostic factor (Figure 3, Table 1). This evidence concerns the gene CD24 and diffuse large B-cell lymphoma.